Gunasekaran Kulothungan, Winans Amanda R McFee, Murthi Swetha, Ahmad Mudassar Raees, Kaatz Scott
Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI, USA.
Department of Pharmaceutical Care Services, Section of Clinical Pharmacy, Bassett Medical Center, Cooperstown, NY, USA.
Clin Pract. 2017 Aug 1;7(3):957. doi: 10.4081/cp.2017.957. eCollection 2017 Jun 7.
Apixaban is an oral anticoagulant that directly inhibits Factor Xa and is indicated for the prophylaxis and treatment of deep venous thrombosis and stroke prevention in non-valvular atrial fibrillation. Rectus sheath hematoma is a rare, life-threatening complication of anticoagulant treatment. We describe a case of an elderly patient on apixaban for the treatment of deep venous thrombosis who developed severe abdominal pain during hospitalization. Computed tomography of the abdomen revealed left rectus sheath hematoma. Apixaban was discontinued and the patient was monitored for extension of the hematoma. After 2 days she was discharged home. Outpatient computed tomography 1 month later showed complete resolution of the rectus sheath hematoma. We recommend that clinicians become aware of the potential for rare and serious bleeding complications of anticoagulants and identify the need for early recognition and prompt management.
阿哌沙班是一种直接抑制凝血因子Xa的口服抗凝剂,适用于非瓣膜性心房颤动患者深静脉血栓形成的预防和治疗以及中风预防。腹直肌鞘血肿是抗凝治疗罕见的、危及生命的并发症。我们描述了一例老年患者,正在接受阿哌沙班治疗深静脉血栓形成,住院期间出现严重腹痛。腹部计算机断层扫描显示左腹直肌鞘血肿。停用阿哌沙班并对患者进行血肿扩展监测。2天后患者出院回家。1个月后的门诊计算机断层扫描显示腹直肌鞘血肿完全消退。我们建议临床医生应意识到抗凝剂存在罕见且严重的出血并发症的可能性,并认识到早期识别和及时处理的必要性。